ACL.AX

Healthcare Diagnostics & Research

Australian Clinical Labs Limited

A$2.81

+0.02 +0.72% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 5, 2026, live at 10:36 AM ET	2.81

Key Stats

Market Cap

524.12M

Avg Volume

684,075

P/E (TTM)

23.42

EPS

A$0.12

52W High

A$3.03

52W Low

A$1.83

Div. Yield

4.7%

Analyst Ratings

Hold

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

13.80

P/B Ratio

3.48

P/S Ratio

0.71

EV/EBITDA

10.12

EV/Revenue

1.13

Margins

Gross Margin 38.1%

Operating Margin 11.2%

Net Margin 3.2%

EBITDA Margin 11.1%

Growth & Returns

Revenue Growth (YoY)

(0.4%)

Earnings Growth (YoY)

(8.7%)

Earnings Growth (QoQ)

(12.5%)

Return on Equity

14.9%

Return on Assets

7.4%

Liquidity & Leverage

Current Ratio

0.54

Quick Ratio

0.44

Debt / Equity

2.25

Total Cash

25.66M

Total Debt

337.40M

About

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services. It also provides workplace services, environmental screening, and clinical trial services. The company offers its services under the SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology brands. It serves doctors, patients, and corporate clients. The company was founded in 2015 and is headquartered in Clayton, Australia.